GlobeNewswire Inc.··Not SpecifiediDEL Therapeutics Names Ulbrich as Board Chair, Secures €9M Seed Round
iDEL Therapeutics appoints Dr. Claudia Ulbrich as Board Chair and secures €9M seed funding led by BiomedVC to advance its novel cancer drug delivery platform.
NVObiotechclinical development